(19)
(11) EP 1 290 196 A1

(12)

(43) Date of publication:
12.03.2003 Bulletin 2003/11

(21) Application number: 00941479.8

(22) Date of filing: 16.06.2000
(51) International Patent Classification (IPC)7C12N 15/62, C12N 15/63, C12N 15/67, C12N 15/86, C12N 7/01, C12N 5/10, C07K 14/47, C12Q 1/68, A01K 67/027, A61K 48/00
(86) International application number:
PCT/US0016/621
(87) International publication number:
WO 0109/8507 (27.12.2001 Gazette 2001/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(71) Applicant: ARIAD GENE THERAPEUTICS, INC.
Cambridge, MA 02139-4234 (US)

(72) Inventors:
  • NATESAN, Sridaran
    Chestnut Hill, MA 02167 (US)
  • GILMAN, Michael, Z.
    Newton, MA 02168 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) CHIMERIC HSF TRANSCRIPTION FACTORS